Rising Biosciences (RBII) Stock Statistics & Valuation Metrics

Rising Biosciences has a market cap or net worth of ―. The enterprise value is ―.

Rising Biosciences has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Rising Biosciences’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -851.70%.

The current PE Ratio of Rising Biosciences is ―. Rising Biosciences’s PEG ratio is -0.26.

In the last 12 months, Rising Biosciences had revenue of 782.28K and earned 49.76K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Rising Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Rising Biosciences upcoming earnings date is ―, ―.

Rising Biosciences as a current ratio of 0.12, with Debt / Equity ratio of ―

In the past 12 months, Rising Biosciences has paid 0.00 in taxes.

Rising Biosciences EV to EBITDA ratio is 14.93, with an EV/FCF ratio of -32.41.

Rising Biosciences has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 36.33%, and net profit margin of 6.36%.

The average price target for Rising Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―